Epicardial Adipose Tissue, Functional Status, and Invasive Hemodynamics in Heart Failure With Preserved Ejection Fraction
Open Access
- 27 August 2025
- journal article
- research article
- Published by Elsevier in JACC: Advances
- Vol. 4 (12) , 102185
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection FractionJAMA Cardiology, 2024
- Cardiovascular Significance and Genetics of Epicardial and Pericardial AdiposityJAMA Cardiology, 2024
- Epicardial Adipose Tissue and Pericardial Constraint in Heart Failure with Preserved Ejection FractionESC Heart Failure, 2024
- Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II TrialEuropean Journal of Heart Failure, 2023
- Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectivesEuropean Journal of Heart Failure, 2022
- Association of epicardial adipose tissue with proteomics, coronary flow reserve, cardiac structure and function, and quality of life in heart failure with preserved ejection fraction: insights from the PROMIS‐HFpEF studyEuropean Journal of Heart Failure, 2022
- The Value of Echocardiographic Measurement of Epicardial Adipose Tissue in Heart Failure PatientsESC Heart Failure, 2022
- Uncoupling between intravascular and distending pressures leads to underestimation of circulatory congestion in obesityEuropean Journal of Heart Failure, 2021
- Myocardial Adipose Deposition and the Development of Heart Failure with Preserved Ejection FractionEuropean Journal of Heart Failure, 2019
- Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection FractionJAMA, 2016